From product information to reimbursement codes, bdipharma.com serves as a significant resource to the customer, providing valuable information from the start of treatment to the conclusion of therapy.
Columbia, SC (PRWEB) May 26, 2011
BDI Pharma, Inc., the nation’s fastest growing distributor of biotech therapies, announced a new record number of daily hits on the company’s corporate web site, bdipharma.com. Since April, the daily count has exceeded well over 31,000 hits on multiple occasions. As for an average, the site is tracking well over 24,000 hits on a daily basis for all of 2011 to date.
“Over the years, we have been very cognizant to the fact that our customers are relying more and more on web-based resources for accessing clinical information,” stated Brad Davis, Assistant Vice President of Marketing for BDI Pharma. “Designed to be a robust and dynamic source for critical information, product specifications and market data, bdipharma.com is an open-access site free to the healthcare community, payors, educational institutions and, of course, to patients looking to learn more about the treatment they are receiving.”
“Many of our trade partners recognize a great value in the quality of exposure they receive, as can be seen from the multiple product advertisements placed on the site,” added Candace Engel, BDI Pharma Web Developer. “From product information to reimbursement codes, bdipharma.com serves as a significant resource to the customer, providing valuable information from the start of treatment to the conclusion of therapy.”
About BDI Pharma, Inc.
Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs for specialty veterinarians -- 4legpharma.com; product consignment -- consignadvantage.com; flu vaccine pre-booking and general vaccine ordering -- securivax.com; and purchasing/reward programs -- qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.
BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.